US 11421284
Methods for predicting drug responsiveness in cancer patients
granted A61KA61K31/122A61K45/06
Quick answer
US patent 11421284 (Methods for predicting drug responsiveness in cancer patients) held by Allarity Therapeutics Europe ApS expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Allarity Therapeutics Europe ApS
- Grant date
- Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/122, A61K45/06, A61K9/0019